Similar articles

• Letter: Nutmeg and prostaglandins.

  Dietz WH Jr, Stuart MJ. Dietz WH Jr, et al. N Engl J Med. 1976 Feb 26;294(9):503. N Engl J Med. 1976. PMID: 942762 No abstract available.
• Letter: Nutmeg and medullary carcinoma of thyroid.

  Shafran I, McCrone D. Shafran I, et al. N Engl J Med. 1975 Dec 11;293(24):1266. N Engl J Med. 1975. PMID: 1237796 No abstract available.
• Leukotrienes in Crohn's disease: effect of sulfasalazine and 5-aminosalicylic acid.

  Dreyling KW, Hoppe U, Peskar BA, Schaarschmidt K, Peskar BM. Dreyling KW, et al. Adv Prostaglandin Thromboxane Leukot Res. 1987;17A:339-43. Adv Prostaglandin Thromboxane Leukot Res. 1987. PMID: 2889333 No abstract available.
• [Behçet's disease associated with Crohn's disease].

  Houman H, Ben Dahmen F, Ben Ghorbel I, Chouaib S, Lamloum M, Kchir N, Ben Ammar A, Miled M. Houman H, et al. Ann Med Interne (Paris). 2001 Nov;152(7):480-2. Ann Med Interne (Paris). 2001. PMID: 11965089 Review. French.
• Oral mesalazine for the treatment of Crohn's disease: clinical efficacy with respect to pharmacokinetic properties.

  Tromm A, Griga T, May B. Tromm A, et al. Hepatogastroenterology. 1999 Nov-Dec;46(30):3124-35. Hepatogastroenterology. 1999. PMID: 10626173 Review.